Akorn Inc. has recalled approximately 16,078 bottles of Hydrocortisone and Acetic Acid Otic Solution (10 mL), a prescription ear drop medication. The recall was initiated because laboratory testing found the hydrocortisone portion of the drug was subpotent, meaning it may not contain the full amount of active medication required. This quality issue was discovered after the product failed out-of-specification assay tests, which could impact the effectiveness of the treatment.
A subpotent drug may not provide the intended therapeutic effect, potentially leading to inadequate treatment of the underlying ear condition for which it was prescribed. While no specific injuries or adverse events were reported in this data, the lack of full medicinal strength can delay recovery or allow symptoms to persist.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.